About Us
Hepatitis B and C Public Policy Association asbl
In April 2009 a group of leading European scientists, professors, public health experts and patient advocates created the Hepatitis B and C Summit Conferences Association as a Luxembourg-based not-for-profit Association (association sans but lucratif). The Association aimed primarily to deliver a summit conference on Hepatitis B and C in Europe, which was held in Brussels in October 2010 under the auspices of the Belgian EU Presidency.
The Association acknowledges with grateful thanks the support of the European Association for the Study of the Liver (EASL), the European Centre for Disease Prevention and Control (ECDC), the European Commission’s Directorate-General for Health and Consumers (DG SANCO), the European Monitoring Centre for Drugs and Drug Addiction (EMDCCA), the European Liver Patients Association (ELPA), the Viral Hepatitis Prevention Board (VHPB), the World Health Organisation – Europe (WHO-Europe) and the World Hepatitis Alliance (WHA) in its past activities.
Hepatitis B&C Public Policy Association is a founding member of the ACHIEVE coalition (Associations Collaborating on Hepatitis to Immunize and Eliminate the Viruses in Europe) which calls on the EU to take action to eliminate hepatitis B and C in Europe by 2030.
The Association’s work in the field of viral hepatitis B and C will continue to be developed in collaboration with the stakeholders mentioned above.
In June 2011 the Association’s name was changed to Hepatitis B and C Public Policy Association to reflect the broader, continuing activities of the Association (see Activities).
Financial contributions received in support of the Association’s activities are made directly to the Association’s Luxembourg bank account, and are disbursed at the discretion of its Directors. The current Sponsors of Hepatitis B&C Public Policy Association are: Gilead Sciences, AbbVie and MSD.
The auditors to the Association are Grant Thornton Lux Audit and Assurance S.A., 83 Pafebruch, L-9308 Capellen, Luxembourg.
The Directors and members of the Association ensure and uphold its independence from its sponsors and other external partners.
Meet The Directors & Members of the Association
Co-Chairs
Prof. Angelos Hatzakis MD PhD
Professor of Epidemiology and Preventive Medicine Head, National Retrovirus Reference Centre Director, Department of Hygiene, Epidemiology & Medical Statistics Athens University Medical School, Greece
BIOGProf. Michael Manns MD
Professor and Chairman, Department of Gastroenterology, Hepatology and Endocrinology, Hannover Medical School (MHH)
Director, Centre for Individualised Infection Medicine (CIIM), Hannover
Clinical Director, Helmholtz Centre for Infection Research (HZI), Braunschweig, Germany
BIOGProf. Rafael Esteban MD
Liver Unit, Department of Internal Medicine, Vall d’Hebron University Hospital, Barcelona, Spain.
BIOGTreasurer
Prof. George V. Papatheodoridis MD PhD
National and Kapodistrian University of Athens Medical School, Greece
BIOG
Members
Prof. Maria Buti
Liver Unit, Department of Internal Medicine, Vall d’Hebron University Hospital, Barcelona, Spain
BIOG
Dr. Manuel Carballo
Executive Director, International Centre for Migration and Health (ICMH), Geneva, Switzerland
BIOG
Prof. Laurent Castera
Department of Hepatology Hôpital Beaujon, AP-HP INSERM U773, University of Paris-VII, Clichy, France
BIOG
Prof. Massimo Colombo
Head, Liver Center for Translational Research, IRCCS Humanitas, Milan, Italy
Chairman of the EASL International Liver Foundation, Geneva, Switzerland.
Prof. Antonio Craxi
Director, Gastroenterology and Internal Medicine University of Palermo, Italy
BIOG
Prof. Gamal Esmat MD
Professor of Hepatogastroenterology & Infectious Diseases Past Vice President of Cairo University, Egypt Egyptian Nile Award in Science 2016 State Merit Award in Medical Science 2010 WHO STAC Member Past President of International Association for Study of Liver Diseases
BIOG
Mr. George Kalamitsis
Chair, Hellenic Patients Association “Prometheus”, Athens, Greece.
BIOG
Prof Jeffrey V. Lazarus
Associate Professor, University of Barcelona
Associate Researcher, ISGlobal, Hospital Clínic, University of Barcelona
Dr. Ricardo Baptista Leite
Member of Portuguese Parliament – Head of Public Health – Medical Doctor – University Professor -Public Health Advocate
BIOG
Dr. David Goldberg
Health Protection Scotland Centre for Virus Research Glasgow, Scotland
BIOG
Mr. Charles Gore
Executive Director of The Medicines Patent Pool (MPP) Governance Board, Geneva, Switzerland.
BIOG
Prof. Harry Janssen
Head, UHN Liver Clinic, Toronto Western Hospital, Canada
BIOG
Prof. Patrick Marcellin
Service d’Hépatologie, Hôpital Beaujon, APHP University of Paris, France
BIOG
Mr. Michael Ninburg
President, World Hepatitis Alliance
BIOG
Prof. Markus Peck-Radosavljevic
Professor of Medicine Chair, Dept. of Internal Medicine and Gastroenterology (IMuG) Hepatology, Endocrinology, Rheumatology and Nephrology Centralized Emergency Service (ZAE) Klinikum Klagenfurt am Wörthersee Klagenfurt, Austria
BIOG
Prof. Howard Thomas
Professor Emeritus, Hepatology and Gastroenterology, Imperial College, London, UK.
BIOG
Prof. Mark Thursz
Professor of Hepatology Imperial College, London, UK
BIOG
Prof. Nurdan Tozun
Vice Rector, Acibadem University Acibadem Kozyatagi Hospital Dept of Gastroenterology Istanbul, Turkey.
BIOG
Prof. Pierre van Damme
Viral Hepatitis Prevention Board (VHPB) Vaccine and Infectious Disease Institute, Antwerp, Belgium
BIOG
Prof. Heiner Wedemeyer MD
Professor and Chairman, Department of Gastroenterology and Hepatology at the University Clinic Essen, Essen, Germany
BIOGAffiliated Members
Nikos Dedes
President, Association of People Living with HIV in Greece ‘Positive Voice’ Greece.
BIOG